Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer

Overview of attention for article published in Breast Cancer Research, April 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 51 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

METHODS OF TREATING CANCER USING ANDROGEN RECEPTOR ANTAGONISTS

Application EP-4048265-A4

European Patent Office

METHOD FOR DETERMINING BREAST CANCER TREATMENT

Application WO-2014031164-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.